FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel, Switzerland, March 29, 2018. REUTERS/Arnd Wiegmann/File Photo

ZURICH (Reuters) – Novartis has 25 potential blockbuster treatments in development, the company said ahead of a management event in the United States on Thursday.

“Our pipeline is industry-leading with more than 25 potential blockbusters and this pace of innovation positions Novartis well for the future”, said Novartis Chief Executive Vas Narasimhan in a statement.

Reporting by Silke Koltrowitz



READ SOURCE

READ  Moments in your life when you are most prone to putting on weight

WHAT YOUR THOUGHTS

Please enter your comment!
Please enter your name here